NFL: Reports: WFT trainer Ryan Vermillion subject of prescription drug probe

Date:

Share post:


Washington Football Team head trainer Ryan Vermillion is being investigated for illegally distributing prescription drugs, the Washington Post and ESPN reported Thursday.

Federal law enforcement conducted a raid at the team’s practice facility and Vermillion’s home last week. On Monday, Washington placed him on administrative leave, saying in a statement it was “due to an ongoing criminal investigation that is unrelated to the team.”

Vermillion is not a physician, so by law he would not be allowed to disburse prescription drugs.

Earlier Thursday, the NFLPA informed agents that it has begun its own investigation into the matter.

“The work office and home of Ryan Vermillion were raided by the Drug Enforcement Agency, and one of our players has been contacted by federal investigators,” the memo revealed.

According to the initial report from NBC Sports Washington, the investigation into Vermillion has been ongoing for months.

Vermillion is in his second season with Washington after 18 seasons with the Carolina Panthers. He spent nine seasons with Washington coach Ron Rivera in Carolina when Rivera was coach of the Panthers from 2011-19.

–Field Level Media

spot_img

Related articles

NFL: Alabama QB Jalen Milroe blazes 40 at pro day with Steelers front and center

Alabama quarterback Jalen Milroe posted a 40 time in the 4.5-second range at the Crimson Tide pro day...

NFL: Netflix bringing back ‘Quarterback’ for Season 2

Joe Burrow, Kirk Cousins and Jared Goff will star in the second season of the Netflix series "Quarterback." On...

NFL: NFL transactions roundup: Jaguars to sign OT Fred Johnson

The Jacksonville Jaguars will sign offensive tackle Fred Johnson to a one-year contract, his agent told ESPN on...

NFL: Reports: Vikings not signing QB Aaron Rodgers

The Minnesota Vikings are content to proceed with J.J. McCarthy as their quarterback and don't plan to sign...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.